Asasantin SR

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

Dipyridamole; Aspirin

Disponível em:

Boehringer Ingelheim Pty Ltd

Classe:

Medicine Registered

Folheto informativo - Bula

 
CMI0041-08 
1 
ASASANTIN

 SR SUSTAINED RELEASE 
CAPSULES 
_Dipyridamole and Aspirin _
CONSUMER MEDICINE INFORMATION 
WHAT IS IN THIS LEAFLET 
This leaflet answers some common 
questions about Asasantin SR. 
It does not contain all available 
information. 
It does not take the place of talking to 
your doctor or pharmacist.This leaflet 
was last updated on the date at the end 
of this leaflet. More recent 
information may be available. The 
latest Consumer Medicine 
Information is available from your 
pharmacist, doctor, or from 
www.medicines.org.au and may 
contain important information about 
the medicine and its use of which you 
should be aware. 
ASK YOUR DOCTOR OR PHARMACIST IF 
YOU HAVE ANY CONCERNS OR QUESTIONS 
ABOUT TAKING THIS MEDICINE, 
KEEP THIS INFORMATION WITH YOUR 
CAPSULES. 
You may need to read it again. 
WHAT ASASANTIN SR IS 
USED FOR  
Asasantin SR helps to prevent 
recurrence of stroke in people who 
have had a previous stroke or transient 
ischaemic attack (TIA). 
Asasantin SR works by preventing 
blood clots from forming. The ability 
of Asasantin SR to prevent blood clots 
is due to its effect on blood cells 
known as platelets. 
ASK YOUR DOCTOR IF YOU HAVE ANY 
QUESTIONS ABOUT WHY THIS MEDICINE 
HAS BEEN PRESCRIBED FOR YOU.  
Your doctor may have prescribed it 
for another reason 
BEFORE YOU TAKE 
ASASANTIN SR 
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE ASASANTIN SR IF YOU 
HAVE AN ALLERGY TO:  
  aspirin, or NSAIDs, non-steroidal 
anti-inflammatory medicines 
  dipyridamole  
  any of the other ingredients listed 
at the end of this leaflet.  
Some of the symptoms of an allergic 
reaction may include:  
  shortness of breath  
  wheezing or difficulty breathing  
  swelling of the face, lips, tongue 
or other parts of the body  
  rash, itching or hives on the skin  
DO�

Características técnicas

PI0069-09 

1

ASASANTIN

 SR  
SUSTAINED-RELEASE CAPSULES 
NAME OF THE MEDICINE  
ASASANTIN

 SR sustained-release capsules contain the active ingredients
dipyridamole and 
aspirin. 
The structural formulae for dipyridamole and aspirin are as follows: 

Dipyridamole 

Aspirin 
_DIPYRIDAMOLE _
An odourless, yellow crystalline powder with a bitter taste.  It has
a melting point in the range of 
164-168
C, and is soluble in dilute acids, methanol, ethanol
and chloroform.  The molecular 
formula for dipyridamole is C
24
H
40
N
8
O
4
 and the molecular weight is 504.6.  The chemical name for 
dipyridamole is
2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido[5,4-d]pyrimidine.
 The CAS 
number is 58-32-2.

_ASPIRIN _
A white crystalline powder or colourless crystals, odourless
or almost odourless, slightly soluble in 
water, freely soluble in alcohol, soluble in chloroform and
in ether.  It melts at about 143
C.  The 
molecular formula for aspirin is C
9
H
8
O
4
 and the molecular weight is 180.2.  Aspirin is commonly 
known as acetylsalicylic acid.  The chemical name is
2-acetoxybenzoic acid.  The CAS number is 
50-78-2. 
DESCRIPTION 
Each ASASANTIN
 SR sustained-release capsule contains dipyridamole 200 mg and
aspirin      
25 mg.  The inactive ingredients in ASASANTIN 
 SR sustained-release capsules are: tartaric 
acid, povidone, methacrylic acid copolymer (Eudragit S 100), talc,
acacia, hypromellose, 
hypromellose phthalate, glycerol triacetate, dimethicone 350,
stearic acid, lactose, aluminium 
stearate, colloidal anhydrous silica, maize starch, microcrystalline
cellulose, sucrose, gelatin, 
titanium dioxide, iron oxide red CI77491 and iron oxide yellow
CI77492. 
PHARMACOLOGY 
Dipyridamole has an antithrombotic action based on its ability to
modify various aspects of platelet 
function.  It causes inhibition of platelet adhesion and
aggregation, particularly in diseased states 
where platelet